
AI Generated Leaderboard of #ELCC25 KOL Influencers
Doctor Name & Image | Total Engagements | Total Impressions | Notable KOL Interactions | Influential Topics | Top Tweet Link |
---|---|---|---|---|---|
Noemi Reguart![]() | 301 (224 likes, 77 RTs) | 18,101 | @marinagarassino, @OncoAlert, @myESMO | MARIPOSA trial, EGFR+ NSCLC | View Tweet |
Giannis Mountzios![]() | 145 (106 likes, 39 RTs) | 6,986 | @ZPiotrowskaMD, @APassaroMD | EGFR+ NSCLC treatment debates | View Tweet |
Eric K. Singhi![]() | 148 (117 likes, 31 RTs) | 32,860 | @OncoAlert, @OncBrothers | MARIPOSA trial updates | View Tweet |
Benjamin Besse![]() | 171 (131 likes, 40 RTs) | 6,882 | @OncoAlert, @myESMO | EGFR treatment strategies | View Tweet |
Stephen V Liu![]() | 155 (120 likes, 35 RTs) | 10,450 | @PrelajArsela, @myESMO | MARIPOSA & LAURA trials | View Tweet |
Jill Feldman![]() | 116 (90 likes, 26 RTs) | 8,400 | @EGFRResisters, @lungoncdoc | Patient advocacy, COCOON trial | View Tweet |
Jarushka Naidoo![]() | 49 (40 likes, 9 RTs) | 1,123 | @BenjaminBesseMD, @myESMO | MARIPOSA, KRYSTAL-7 trials | View Tweet |
Antonio Calles![]() | 89 (71 likes, 18 RTs) | 5,491 | @DrSanjayPopat, @OncoAlert | Subcutaneous pembrolizumab | View Tweet |
Bartomeu Massuti![]() | 85 (56 likes, 29 RTs) | 6,501 | @myESMO, @OncoAlert | EGFR mutation landscape | View Tweet |
Julien Mazieres![]() | 89 (71 likes, 18 RTs) | 4,875 | @OncoAlert, @myESMO | MARIPOSA trial toxicity | View Tweet |
Doctor Name & Image | Total Engagements | Total Impressions | Notable KOL Interactions | Influential Topics | Top Tweet Link |
---|---|---|---|---|---|
Noemi Reguart![]() | 301 (224 likes, 77 RTs) | 18,101 | @marinagarassino, @OncoAlert, @myESMO | MARIPOSA trial, EGFR+ NSCLC | View Tweet |
Giannis Mountzios![]() | 145 (106 likes, 39 RTs) | 6,986 | @ZPiotrowskaMD, @APassaroMD | EGFR+ NSCLC treatment debates | View Tweet |
Eric K. Singhi![]() | 148 (117 likes, 31 RTs) | 32,860 | @OncoAlert, @OncBrothers | MARIPOSA trial updates | View Tweet |
Benjamin Besse![]() | 171 (131 likes, 40 RTs) | 6,882 | @OncoAlert, @myESMO | EGFR treatment strategies | View Tweet |
Stephen V Liu![]() | 155 (120 likes, 35 RTs) | 10,450 | @PrelajArsela, @myESMO | MARIPOSA & LAURA trials | View Tweet |
Jill Feldman![]() | 116 (90 likes, 26 RTs) | 8,400 | @EGFRResisters, @lungoncdoc | Patient advocacy, COCOON trial | View Tweet |
Jarushka Naidoo![]() | 49 (40 likes, 9 RTs) | 1,123 | @BenjaminBesseMD, @myESMO | MARIPOSA, KRYSTAL-7 trials | View Tweet |
Antonio Calles![]() | 89 (71 likes, 18 RTs) | 5,491 | @DrSanjayPopat, @OncoAlert | Subcutaneous pembrolizumab | View Tweet |
Bartomeu Massuti![]() | 85 (56 likes, 29 RTs) | 6,501 | @myESMO, @OncoAlert | EGFR mutation landscape | View Tweet |
Julien Mazieres![]() | 89 (71 likes, 18 RTs) | 4,875 | @OncoAlert, @myESMO | MARIPOSA trial toxicity | View Tweet |
Some of the most helpful use cases of AI development include the rapid prototyping of data visualizations and the organization of large amounts of data. This is an example of a use case where I'd like to identify the Leaders of the recent European Lung Cancer Congress 2025, #ELCC25, and provide links to their top tweets with mentions of their notable topic of influence. For this demo, I used the KOL Pulse AI tool with advanced LLM interface. I had some problems with my prompting, so I asked CHAT GPT (off the shelf) to help me out with a better prompt.
Data Sources: The KOL Pulse AI tool allows for a user to bookmark tweets and tag them based on KOL and topics. These data are then organized in our database.
AI Model: We use a custom KOL Pulse AI Wrapper optimized to KOL social media discussions to generate the output.
Here's the Prompt I used based on feedback from Chat GPT:
Please create an HTML table styled with a blue border and light blue background to present a NASCAR-style leaderboard for the top 10 doctors on X (formerly Twitter). Each row should include:
The doctor's name displayed above their X profile image.
The total engagements of their tweets.
The total impressions of their tweets.
Notable Key Opinion Leaders (KOLs) they engage with on X.
Their influential topics.
A hyperlink to their top tweet.
Ensure the table includes exactly 10 rows for the top 10 doctors and that the 'Total Engagements' column presents data in a clear and concise manner, avoiding clutter. The table should maintain a professional medical aesthetic
Here's the KOL Pulse AI generated Output of the #ELCC25 KOL Leaderboard
Doctor Name & Image | Total Engagements | Total Impressions | Notable KOL Interactions | Influential Topics | Top Tweet Link |
---|---|---|---|---|---|
Noemi Reguart![]() | 301 (224 likes, 77 RTs) | 18,101 | @marinagarassino, @OncoAlert, @myESMO | MARIPOSA trial, EGFR+ NSCLC | View Tweet |
Giannis Mountzios![]() | 145 (106 likes, 39 RTs) | 6,986 | @ZPiotrowskaMD, @APassaroMD | EGFR+ NSCLC treatment debates | View Tweet |
Eric K. Singhi![]() | 148 (117 likes, 31 RTs) | 32,860 | @OncoAlert, @OncBrothers | MARIPOSA trial updates | View Tweet |
Benjamin Besse![]() | 171 (131 likes, 40 RTs) | 6,882 | @OncoAlert, @myESMO | EGFR treatment strategies | View Tweet |
Stephen V Liu![]() | 155 (120 likes, 35 RTs) | 10,450 | @PrelajArsela, @myESMO | MARIPOSA & LAURA trials | View Tweet |
Jill Feldman![]() | 116 (90 likes, 26 RTs) | 8,400 | @EGFRResisters, @lungoncdoc | Patient advocacy, COCOON trial | View Tweet |
Jarushka Naidoo![]() | 49 (40 likes, 9 RTs) | 1,123 | @BenjaminBesseMD, @myESMO | MARIPOSA, KRYSTAL-7 trials | View Tweet |
Antonio Calles![]() | 89 (71 likes, 18 RTs) | 5,491 | @DrSanjayPopat, @OncoAlert | Subcutaneous pembrolizumab | View Tweet |
Bartomeu Massuti![]() | 85 (56 likes, 29 RTs) | 6,501 | @myESMO, @OncoAlert | EGFR mutation landscape | View Tweet |
Julien Mazieres![]() | 89 (71 likes, 18 RTs) | 4,875 | @OncoAlert, @myESMO | MARIPOSA trial toxicity | View Tweet |
Doctor Name & Image | Total Engagements | Total Impressions | Notable KOL Interactions | Influential Topics | Top Tweet Link |
---|---|---|---|---|---|
Noemi Reguart![]() |
301 (224 likes, 77 RTs) | 18,101 | @marinagarassino, @OncoAlert, @myESMO | MARIPOSA trial, EGFR+ NSCLC | View Tweet |
Giannis Mountzios![]() |
145 (106 likes, 39 RTs) | 6,986 | @ZPiotrowskaMD, @APassaroMD | EGFR+ NSCLC treatment debates | View Tweet |
Eric K. Singhi![]() |
148 (117 likes, 31 RTs) | 32,860 | @OncoAlert, @OncBrothers | MARIPOSA trial updates | View Tweet |
Benjamin Besse![]() |
171 (131 likes, 40 RTs) | 6,882 | @OncoAlert, @myESMO | EGFR treatment strategies | View Tweet |
Stephen V Liu![]() |
155 (120 likes, 35 RTs) | 10,450 | @PrelajArsela, @myESMO | MARIPOSA & LAURA trials | View Tweet |
Jill Feldman![]() |
116 (90 likes, 26 RTs) | 8,400 | @EGFRResisters, @lungoncdoc | Patient advocacy, COCOON trial | View Tweet |
Jarushka Naidoo![]() |
49 (40 likes, 9 RTs) | 1,123 | @BenjaminBesseMD, @myESMO | MARIPOSA, KRYSTAL-7 trials | View Tweet |
Antonio Calles![]() |
89 (71 likes, 18 RTs) | 5,491 | @DrSanjayPopat, @OncoAlert | Subcutaneous pembrolizumab | View Tweet |
Bartomeu Massuti![]() |
85 (56 likes, 29 RTs) | 6,501 | @myESMO, @OncoAlert | EGFR mutation landscape | View Tweet |
Julien Mazieres![]() |
89 (71 likes, 18 RTs) | 4,875 | @OncoAlert, @myESMO | MARIPOSA trial toxicity |
AI Generated Social Network Visualization of the MARIPOSA discussion at #ELCC25
